The laboratory risk assessment and control testing 2019 novel coronavirus in biosafety class II laboratories / 中华检验医学杂志

The outbreak of 2019 Novel Coronavirus (2019-nCoV) has spread from Wuhan to the whole country. After the Spring Festival, workers will return to workplace and students will return to school. There is an increasing risk of 2019-nCoV cases being imported into provinces and cities. In order to promote the prevention and control of 2019-nCoV infection, reduce the risk of transmission in medical institutions, and ensure medical quality and medical safety, it is necessary to carry out the detection test of 2019-nCoV in biosafety class II laboratory. In order to achieve the goal of zero infection of the laboratory personnel, different preventive measures should be taken to assess the risk of the experimental activities.

The laboratory risk assessment and control testing 2019 novel coronavirus in biosafety class Ⅱ laboratories / 中华检验医学杂志

In order to promote the prevention and control of 2019-nCoV infection, reduce the risk of transmission in medical institutions, and ensure medical quality and medical safety, it is necessary to carry out the detection test of 2019-nCoV in biosafety class Ⅱ laboratory. In order to achieve the goal of zero infection of the laboratory personnel, different preventive measures should be taken to assess the risk of the experimental activities.

Point-of-care testing in the diagnosis of infectious diseases / 中华检验医学杂志

Rapid diagnosis is important for the prevention and control of infectious disease.Point-of-care testing (POCT) technology is simple,mobile,rapid,sensitive and accurate.In recent years,POCT has been widely used in the detection of infectious agents.This article reviews the development of POCT in the diagnosis of infectious diseases,focusing on immuno-chromatographic technology,microfluidic chip technology and loop-mediated isothermal amplification (LAMP) technology.